In a significant operation against counterfeit drugs, the Central Drugs Standard Control Organization and the West Bengal Drugs Control Directorate seized a large consignment of suspected spurious anti-cancer and anti-diabetic medicines in Kolkata. The confiscated drugs, valued at approximately ₹6.60 crore, included medications labeled as originating from countries such as Ireland, Turkey, the United States, and Bangladesh, but lacked proper documentation to verify their legitimate importation into India.
Authorities raised serious concerns about the authenticity of the seized products, as investigators also discovered empty packaging materials, further suggesting irregularities in the supply chain. The confiscated items included critical medications such as anti-cancer and anti-diabetic drugs, posing a direct threat to public health if they had reached unsuspecting patients.
Samples of the seized medicines have been sent for quality testing to confirm their authenticity and compliance with regulatory standards. Meanwhile, the rest of the consignment has been placed under secure custody by the Central Drugs Standard Control Organization to prevent any potential misuse.
The investigation led to the arrest of the accused, a woman identified as the proprietor of the wholesale firm involved in the distribution of these drugs. She is currently in judicial custody for 14 days as authorities conduct further interrogation and continue their probe into the broader network responsible for trafficking counterfeit medicines.
The Ministry of Health and Family Welfare reiterated its commitment to protecting public health and ensuring the availability of safe and effective medicines. Emphasizing a zero-tolerance policy toward counterfeit and substandard drugs, the Ministry has pledged to strengthen surveillance and regulatory mechanisms to curb such illegal activities.
This operation is part of a broader nationwide effort to crack down on the circulation of counterfeit medicines, which undermine public trust in the healthcare system and pose severe health risks to consumers. The seizure in Kolkata underscores the importance of coordinated actions between regulatory bodies and law enforcement agencies to dismantle these illegal networks.
With further investigation underway, authorities aim to uncover the full scope of the operation and identify any additional individuals or entities involved in the distribution of counterfeit drugs. The Ministry of Health and Family Welfare’s decisive actions send a clear message of its determination to uphold the integrity of the pharmaceutical supply chain and safeguard the health and safety of Indian citizens.
